Reuters logo
BRIEF-PAION completes patient recruitment in U.S. clinical safety trial of remimazolam
December 20, 2016 / 6:31 AM / 9 months ago

BRIEF-PAION completes patient recruitment in U.S. clinical safety trial of remimazolam

Dec 20(Reuters) - PAION AG :

* Announced on Monday successful completion of patient recruitment in U.S. clinical safety trial of remimazolam in high-risk patients undergoing colonoscopy

* Said no drug-related serious adverse events have been reported

* Headline data expected in the first half of 2017

Source text for Eikon:

Further company coverage:

Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below